Healthcare provider profile · identity verified

Brian P. Massaro, M.D.

Internal Medicine · DETROIT, MI · NPI 1528136074

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	705	198
Amlodipine Besylate	Amlodipine Besylate	657	197
Lisinopril	Lisinopril	655	180
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	469	75
Metformin Hcl	Metformin Hcl	448	136
Alprazolam	Alprazolam	430	91
Losartan Potassium	Losartan Potassium	413	120
Omeprazole	Omeprazole	408	126
Metoprolol Succinate	Metoprolol Succinate	368	110
Tamsulosin Hcl	Tamsulosin Hcl	347	110
Furosemide	Furosemide	323	102
Simvastatin	Simvastatin	314	93
Levothyroxine Sodium	Levothyroxine Sodium	305	84
Hydrochlorothiazide	Hydrochlorothiazide	301	85
Zolpidem Tartrate	Zolpidem Tartrate	217	37
Gabapentin	Gabapentin	215	65
Metoprolol Tartrate	Metoprolol Tartrate	214	61
Eliquis	Apixaban	208	52
Atenolol	Atenolol	204	60
Tramadol Hcl	Tramadol Hcl	191	47
Finasteride	Finasteride	152	41
Nifedipine Er	Nifedipine	152	48
Jardiance	Empagliflozin	145	42
Fluticasone Propionate	Fluticasone Propionate	142	55
Pantoprazole Sodium	Pantoprazole Sodium	140	48
Allopurinol	Allopurinol	133	41
Pravastatin Sodium	Pravastatin Sodium	129	38
Albuterol Sulfate Hfa	Albuterol Sulfate	120	48
Spironolactone	Spironolactone	115	34
Trulicity	Dulaglutide	101	23
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	99	99
Methocarbamol	Methocarbamol	94	26
Glipizide Er	Glipizide	91	21
Meclizine Hcl	Meclizine Hcl	91	37
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	89	29
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	88	27
Triamcinolone Acetonide	Triamcinolone Acetonide	88	51
Meloxicam	Meloxicam	87	31
Rosuvastatin Calcium	Rosuvastatin Calcium	86	28
Metformin Hcl Er	Metformin Hcl	85	25
Sertraline Hcl	Sertraline Hcl	85	28
Benazepril Hcl	Benazepril Hcl	80	22
Glimepiride	Glimepiride	76	21
Trazodone Hcl	Trazodone Hcl	76	21
Carvedilol	Carvedilol	73	24
Ibuprofen	Ibuprofen	71	31
Tizanidine Hcl	Tizanidine Hcl	71	21
Diazepam	Diazepam	68	14
Ventolin Hfa	Albuterol Sulfate	67	31
Lorazepam	Lorazepam	64	14
Venlafaxine Hcl Er	Venlafaxine Hcl	64	20
Potassium Chloride	Potassium Chloride	63	21
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	62	17
Doxycycline Hyclate	Doxycycline Hyclate	60	53
Famotidine	Famotidine	60	20
Ozempic	Semaglutide	60	15
Paroxetine Hcl	Paroxetine Hcl	60	16
Prednisone	Prednisone	60	38
Warfarin Sodium	Warfarin Sodium	53	17
Acetaminophen-Codeine	Acetaminophen With Codeine	52	12
Citalopram Hbr	Citalopram Hydrobromide	50	18
Clonazepam	Clonazepam	50	13
Alendronate Sodium	Alendronate Sodium	49	17
Escitalopram Oxalate	Escitalopram Oxalate	49	20
Isosorbide Mononitrate Er	Isosorbide Mononitrate	49	15
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	48	18
Hydrocortisone	Hydrocortisone	48	25
Ezetimibe	Ezetimibe	47	18
Oxycodone Hcl	Oxycodone Hcl	47	suppressed
Pregabalin	Pregabalin	47	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	46	suppressed
Hydralazine Hcl	Hydralazine Hcl	45	13
Diclofenac Sodium	Diclofenac Sodium	44	22
Celecoxib	Celecoxib	43	15
Digoxin	Digoxin	42	11
Donepezil Hcl	Donepezil Hcl	42	suppressed
Boostrix Tdap	Diphth,pertuss(Acell),tet Vac	41	41
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	39	28
Montelukast Sodium	Montelukast Sodium	39	12
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	38	16
Glipizide	Glipizide	38	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	38	13
Naproxen	Naproxen	37	19
Shingrix	Varicella-Zoster Ge/As01b/Pf	37	32
Colchicine	Colchicine	34	17
Ciprofloxacin Hcl	Ciprofloxacin Hcl	33	29
Clopidogrel	Clopidogrel Bisulfate	33	11
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	33	suppressed
Verapamil Er	Verapamil Hcl	33	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	31	24
Cephalexin	Cephalexin	31	24
Farxiga	Dapagliflozin Propanediol	31	suppressed
Torsemide	Torsemide	30	suppressed
Chlorthalidone	Chlorthalidone	29	suppressed
Duloxetine Hcl	Duloxetine Hcl	29	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	29	suppressed
Novolog Flexpen	Insulin Aspart	29	17
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	29	15
Entresto	Sacubitril/Valsartan	28	suppressed
Temazepam	Temazepam	28	suppressed
Amoxicillin	Amoxicillin	27	18
Nitroglycerin	Nitroglycerin	27	23
Azithromycin	Azithromycin	26	17
Felodipine Er	Felodipine	25	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	24	suppressed
Methadone Hcl	Methadone Hcl	24	suppressed
Xarelto	Rivaroxaban	24	suppressed
Clobetasol Propionate	Clobetasol Propionate	23	16
Doxazosin Mesylate	Doxazosin Mesylate	23	suppressed
Bumetanide	Bumetanide	22	suppressed
Lidocaine	Lidocaine	22	suppressed
Methylprednisolone	Methylprednisolone	22	21
Bupropion Hcl Sr	Bupropion Hcl	21	suppressed
Propranolol Hcl	Propranolol Hcl	21	suppressed
Valacyclovir	Valacyclovir Hcl	21	suppressed
Irbesartan	Irbesartan	20	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	20	suppressed
Estradiol	Estradiol	19	suppressed
Klor-Con M20	Potassium Chloride	18	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	17	suppressed
Indapamide	Indapamide	17	suppressed
Insulin Syringe	Syringe And Needle,insulin,1ml	17	suppressed
Ipratropium Bromide	Ipratropium Bromide	17	12
Lamotrigine	Lamotrigine	17	suppressed
Propranolol Hcl Er	Propranolol Hcl	17	suppressed
Raloxifene Hcl	Raloxifene Hcl	17	suppressed
Aripiprazole	Aripiprazole	16	suppressed
Humalog Kwikpen U-100	Insulin Lispro	16	suppressed
Mounjaro	Tirzepatide	16	suppressed
Mupirocin	Mupirocin	16	11
Ondansetron Hcl	Ondansetron Hcl	16	suppressed
Telmisartan-Hydrochlorothiazid	Telmisartan/Hydrochlorothiazid	16	suppressed
Fluconazole	Fluconazole	15	suppressed
Folic Acid	Folic Acid	15	suppressed
Januvia	Sitagliptin Phosphate	15	suppressed
Ketoconazole	Ketoconazole	15	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	15	suppressed
Sucralfate	Sucralfate	15	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	15	12
Clonidine Hcl	Clonidine Hcl	14	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	14	suppressed
Ondansetron Odt	Ondansetron	14	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	14	suppressed
Enalapril Maleate	Enalapril Maleate	13	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	13	suppressed
Mirtazapine	Mirtazapine	13	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	13	suppressed
Prochlorperazine Maleate	Prochlorperazine Maleate	13	suppressed
Ramipril	Ramipril	13	suppressed
Tradjenta	Linagliptin	13	suppressed
Comfort Ez Pen Needle	Pen Needle, Diabetic	12	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	12	suppressed
Morphine Sulfate Er	Morphine Sulfate	12	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	12	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	12	12
Pulmicort Flexhaler	Budesonide	12	suppressed
Ropinirole Hcl	Ropinirole Hcl	12	suppressed
Tadalafil	Tadalafil	12	suppressed
Terazosin Hcl	Terazosin Hcl	12	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	12	suppressed
Fluocinonide	Fluocinonide	11	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	11	suppressed
Spiriva Respimat	Tiotropium Bromide	11	suppressed
Tiotropium Bromide	Tiotropium Bromide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error